ArticleScience translational medicine2016

Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma.

Timothy F Cloughesy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.